Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIV(mac251) Challenge

Documenti analoghi

• Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIV(mac251) Challenge of Rhesus Macaques
  di: Hidajat, Rachmat, et al.
  Pubblicazione: (2009)
• Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIV(mac251) Rectal Challenge
  di: Tuero, Iskra, et al.
  Pubblicazione: (2015)
• Protection against Mucosal Simian Immunodeficiency Virus SIV(mac251) Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit Boosting
  di: Patterson, L. Jean, et al.
  Pubblicazione: (2004)
• Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIV(mac251) Mucosal Challenge
  di: Demberg, Thorsten, et al.
  Pubblicazione: (2008)
• Dynamics of Memory B-Cell Populations in Blood, Lymph Nodes, and Bone Marrow during Antiretroviral Therapy and Envelope Boosting in Simian Immunodeficiency Virus SIVmac251-Infected Rhesus Macaques
  di: Demberg, Thorsten, et al.
  Pubblicazione: (2012)